Intriguingly, none of the treatments without CD8 T cell transfer prolonged the survival of CML mice, indicating that T cell immunity was crucial for the eradication of CML LSCs. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.